Skip to content

Schrodinger

US · SDGR #2667 by market cap Listed 2020
22.93 -3.41 -12.95%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 30 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.5 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
103.13% -0.54pp
Institutions
317 +30
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund59.23%
Foundation21.51%
Hedge Fund15.84%
Public Company3.31%
Individual/Insider2.52%
Private Company1.55%
Government Pension Fund0.89%
Insurance Company0.60%
Family Office/Trust0.15%
Other0.82%

Top holders as of 2026-06-30

Bill & Melinda Gates Foundation Asset Trust 21.51% · 16.15M sh
BlackRock 13.71% · 10.29M sh
Rubric Capital Management LP 8.52% · 6.40M sh
Vanguard Portfolio Management, LLC 5.14% · 3.86M sh
Vanguard Capital Management, LLC 3.56% · 2.68M sh
UBS Asset Management 3.45% · 2.59M sh
Sumitomo Mitsui Trust Asset Management 3.41% · 2.55M sh
Amova Asset Management 3.40% · 2.55M sh
ARK Investment Management LLC 3.16% · 2.37M sh
AQR Capital Management 2.59% · 1.94M sh
State Street Global Advisors 3.10% · 2.33M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 27 buys · 20 sells

NameRoleStake
Bill & Melinda Gates Foundation Asset Trust -- 21.51%
Richard Friesner Co-Founder, Scientific Advisory Chairman and Director 1.87%
Ramy Farid Chief Executive Officer 0.36%
Kenneth Lorton Executive VP, CTO & COO of Software 0.05%
Gary Sender Independent Director 0.02%
Nancy Thornberry Independent Director 0.02%
Jeffrey Chodakewitz Independent Director 0.02%
Michael Lynton Independent Chairperson 0.02%
Gary Ginsberg Independent Director 0.02%
Rosana Kapeller-Libermann Independent Director 0.02%
Arun Oberoi Independent Director 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-10 Robert Abel Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D Open Market Disposition -1,678 $34.00
2026-11-10 Robert Abel Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D Derivative Exercise and Sale -21,927 $17.00–34.00
2026-11-10 Paul Davie Executive VP, Chief Commercial Officer, Global Head of Software Sales & Marketing Other Acquisition +18,400 --
2026-11-10 Paul Davie Executive VP, Chief Commercial Officer, Global Head of Software Sales & Marketing Other Derivative Acquisition +110,600 $31.52
2026-11-08 Yvonne Tran Corporate Secretary, Chief Legal & People Officer Derivative Exercise and Sale -32,000 $17.00–33.11
2026-09-16 Karen Akinsanya President, Head of Therapeutics R&D and Chief Strategy Officer & Partnerships Derivative Exercise and Sale -31,599 $4.34–30.00
2026-07-15 Richie Jain Chief Financial Officer Automatic Disposition -875 $15.60
2026-06-30 Mannix Aklian -- Intent to Sell (Form 144) -1,136 $16.68
2026-06-25 Richard Friesner Co-Founder, Scientific Advisory Chairman and Director Other Acquisition +679,373 --
2026-06-25 Richard Friesner Co-Founder, Scientific Advisory Chairman and Director Other Disposition -679,373 --
2026-06-21 Michael Lynton Independent Chairperson Other Acquisition +8,141 --
2026-06-21 Michael Lynton Independent Chairperson Other Derivative Acquisition +13,313 $15.23
2026-06-21 Gary Ginsberg Independent Director Other Acquisition +8,141 --
2026-06-21 Gary Ginsberg Independent Director Other Derivative Acquisition +13,313 $15.23
2026-06-21 Gary Sender Independent Director Other Acquisition +8,141 --
2026-06-21 Gary Sender Independent Director Other Derivative Acquisition +13,313 $15.23
2026-06-21 Arun Oberoi Independent Director Other Acquisition +8,141 --
2026-06-21 Arun Oberoi Independent Director Other Derivative Acquisition +13,313 $15.23
2026-06-21 Rosana Kapeller-Libermann Independent Director Other Acquisition +8,141 --
2026-06-21 Rosana Kapeller-Libermann Independent Director Other Derivative Acquisition +13,313 $15.23

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Schrodinger discussion 0 comments

Add a comment